Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Oct;101(2):291–296. doi: 10.1111/j.1476-5381.1990.tb12703.x

High- and low-affinity binding sites for [3H]-alpha, beta-methylene ATP in rat urinary bladder membranes.

X N Bo 1, G Burnstock 1
PMCID: PMC1917690  PMID: 2257437

Abstract

1. The characteristics of [3H]-alpha, beta-methylene adenosine 5'triphosphate ([3H]-alpha, beta-MeATP) binding to membrane preparations of rat urinary bladder detrusor were studied. 2. The rat bladder membrane preparation was obtained by multiple centrifugation. [3H]-quinuclidinyl benzilate [( 3H]-QNB) binding to this preparation demonstrated that the muscarinic receptor density was 4.32 times higher than that in the homogenate. [3H]-alpha, beta-MeATP binding was increased 3.88 times. 3. Saturation analysis revealed that the rat bladder membrane contained a high density of [3H]-alpha, beta-MeATP binding sites, which could be divided into a high-affinity component (Kd = 8.1-8.9 nM) and a low-affinity component (Kd = 67.0-119.8 nM). 4. Magnesium ions inhibited the maximum binding in a concentration-dependent manner. The maximum high-affinity binding was reduced from 10.32 pmol mg-1 protein in magnesium-free buffer to 4.62 pmol mg-1 protein with 25 mM MgCl2, while the maximum low-affinity binding was reduced from 58.84 pmol mg-1 protein to 14.24 pmol mg-1 protein. Kd values were not greatly affected. 5. The binding was a rapid reversible process. The association rate constants were 7.64 x 10(7) M-1 min-1 for high-affinity binding, and 7.31 x 10(6) M-1 min-1 for low-affinity binding. The dissociation rate constants were 0.2896 min-1 for high-affinity binding, and 0.6348 min-1 for the low-affinity binding. 6. Displacement experiments with unlabelled purinoceptor ligands confirmed that [3H]-alpha, beta-MeATP mainly binds to P2X-purinoceptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acevedo C. G., Contreras E. Possible involvement of adenine nucleotides in the neurotransmission of the mouse urinary bladder. Comp Biochem Physiol C. 1985;82(2):357–361. doi: 10.1016/0742-8413(85)90176-8. [DOI] [PubMed] [Google Scholar]
  2. Batra S. Use of 3H-QNB in the isolation of plasma membrane from smooth muscle of the urinary bladder: effect of oxalate on calcium uptake by the membrane fractions. Experientia. 1986 Jun 15;42(6):608–611. doi: 10.1007/BF01955556. [DOI] [PubMed] [Google Scholar]
  3. Bo X. N., Burnstock G. [3H]-alpha, beta-methylene ATP, a radioligand labelling P2-purinoceptors. J Auton Nerv Syst. 1989 Oct;28(1):85–88. doi: 10.1016/0165-1838(89)90010-6. [DOI] [PubMed] [Google Scholar]
  4. Burnstock G., Cocks T., Crowe R., Kasakov L. Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol. 1978 May;63(1):125–138. doi: 10.1111/j.1476-5381.1978.tb07782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burnstock G., Dumsday B., Smythe A. Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol. 1972 Mar;44(3):451–461. doi: 10.1111/j.1476-5381.1972.tb07283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  7. Cooper C. L., Morris A. J., Harden T. K. Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor. J Biol Chem. 1989 Apr 15;264(11):6202–6206. [PubMed] [Google Scholar]
  8. Cooper D. M., Yeung S. M., Perez-Reyes E., Fossom L. H. A central role for magnesium in the regulation of inhibitory adenosine receptors. Adv Exp Med Biol. 1984;175:17–30. doi: 10.1007/978-1-4684-4805-4_2. [DOI] [PubMed] [Google Scholar]
  9. Dean D. M., Downie J. W. Contribution of adrenergic and "purinergic" neurotransmission to contraction in rabbit detrusor. J Pharmacol Exp Ther. 1978 Nov;207(2):431–445. [PubMed] [Google Scholar]
  10. Dunn P. M., Blakeley A. G. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol. 1988 Feb;93(2):243–245. doi: 10.1111/j.1476-5381.1988.tb11427.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goodman R. R., Cooper M. J., Gavish M., Snyder S. H. Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes. Mol Pharmacol. 1982 Mar;21(2):329–335. [PubMed] [Google Scholar]
  12. Hourani S. M., Welford L. A., Cusack N. J. L-AMP-PCP, an ATP receptor agonist in guinea-pig bladder, is inactive on taenia coli. Eur J Pharmacol. 1985 Jan 22;108(2):197–200. doi: 10.1016/0014-2999(85)90726-5. [DOI] [PubMed] [Google Scholar]
  13. Hoyle C. H., Chapple C., Burnstock G. Isolated human bladder: evidence for an adenine dinucleotide acting on P2X-purinoceptors and for purinergic transmission. Eur J Pharmacol. 1989 Dec 12;174(1):115–118. doi: 10.1016/0014-2999(89)90881-9. [DOI] [PubMed] [Google Scholar]
  14. Hoyle C. H., Knight G. E., Burnstock G. Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol. 1990 Mar;99(3):617–621. doi: 10.1111/j.1476-5381.1990.tb12979.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Husted S., Sjögren C., Andersson K. E. Direct effects of adenosine and adenine nucleotides on isolated human urinary bladder and their influence on electrically induced contractions. J Urol. 1983 Aug;130(2):392–398. doi: 10.1016/s0022-5347(17)51175-1. [DOI] [PubMed] [Google Scholar]
  16. Hüttemann E., Ukena D., Lenschow V., Schwabe U. Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity. Naunyn Schmiedebergs Arch Pharmacol. 1984 Mar;325(3):226–233. doi: 10.1007/BF00495948. [DOI] [PubMed] [Google Scholar]
  17. Keppens S., De Wulf H. Characterization of the liver P2-purinoceptor involved in the activation of glycogen phosphorylase. Biochem J. 1986 Dec 1;240(2):367–371. doi: 10.1042/bj2400367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Keppens S., Vandekerckhove A., De Wulf H. Characterization of purinoceptors present on human liver plasma membranes. FEBS Lett. 1989 May 8;248(1-2):137–140. doi: 10.1016/0014-5793(89)80448-x. [DOI] [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. Levin R. M., Jacoby R., Wein A. J. High-affinity, divalent ion-specific binding of 3H-ATP to homogenate derived from rabbit urinary bladder. Comparison with divalent-ion ATPase activity. Mol Pharmacol. 1983 Jan;23(1):1–7. [PubMed] [Google Scholar]
  21. Moss H. E., Burnstock G. A comparative study of electrical field stimulation of the guinea-pig, ferret and marmoset urinary bladder. Eur J Pharmacol. 1985 Aug 27;114(3):311–316. doi: 10.1016/0014-2999(85)90375-9. [DOI] [PubMed] [Google Scholar]
  22. Theobald R. J., Jr The effect of arylazido aminopropionyl ATP on atropine resistant contractions of the cat urinary bladder. Life Sci. 1983 May 23;32(21):2479–2484. doi: 10.1016/0024-3205(83)90374-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES